Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
X-linked spondyloepiphyseal dysplasia tarda is an inherited skeletal disorder that affects males only. Physical characteristics include moderate short-stature (dwarfism); moderate to severe spinal deformities; barrel-chest; disproportionately short trunk and neck;disproportionatelylong arms,and premature osteoarthritis, especially in the hip joints. Final male adult height ranges from 4 feet 10 inches to 5 feet 6 inches. Other skeletal features of this condition include decreased mobility of the elbow and hip joints, arthritis, and abnormalities of the hip joint which causes the upper leg bones to turn inward. This condition is caused by mutations in the TRAPPC2 gene and is inherited in an X-linked recessive pattern.
Features include always present findings: Barrel-shaped chest, Hump-shaped mound of bone in central and posterior portions of vertebral endplate, Short femoral neck, and Platyspondyly and others. 21 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 9 | Sideways curvature of the spine (scoliosis), Limitation of joint mobility, Hump-shaped mound of bone in central and posterior portions of vertebral endplate |
Growth and development | 2 | Disproportionate short-trunk short stature, Postnatal growth retardation |
Eyes | 1 | Opacification of the corneal stroma |
Muscles | 1 | Limitation of joint mobility |
Age of onset: adolescence.
Males. At birth, affected males are normal in length and have normal body proportions. Affected males exhibit linear growth deficiency beginning around grade school (age 6-8 years). Adults with X-linked spondyloepiphyseal dysplasia tarda (X-linked SEDT) have disproportionately short stature with short trunk and arm span significantly greater than height. Final adult height is typically 137-163 cm . Scoliosis/kyphoscoliosis and odontoid hypoplasia are known radiographic features. Data on the incidence, onset, and severity of these features have not been published. Osteoarthritis. Progressive joint and back pain with osteoarthritis ensues; hip, knee, and shoulder joints are commonly involved to variable degrees. Hip replacement is often required as early as age 40 years.
Source: GeneReviews — "X-Linked Spondyloepiphyseal Dysplasia Tarda"
TRAPPC2 function has not been fully characterized.
Spondyloepiphyseal dysplasia tarda, X-linked is associated with mutations in the TRAPPC2 gene on chromosome X.
Data are inadequate to reliably correlate clinical severity to a specific TRAPPC2 pathogenic variant. All pathogenic variants identified thus far, irrespective of their molecular basis, result in an almost identical phenotype, including the true null variants.
Source: GeneReviews — "X-Linked Spondyloepiphyseal Dysplasia Tarda"
No consensus clinical diagnostic criteria for X-linked spondyloepiphyseal dysplasia tarda have been published.
X-linked spondyloepiphyseal dysplasia tarda (X-linked SEDT) should be suspected in males with the following findings:
Source: GeneReviews — "X-Linked Spondyloepiphyseal Dysplasia Tarda"
X-linked spondyloepiphyseal dysplasia tarda (X-linked SEDT) is distinguished from other forms of spondyloepiphyseal dysplasia (SED) by its later onset and X-linked inheritance . Table 2. Forms of Spondyloepiphyseal Dysplasia of Interest in the Differential Diagnosis of X-Linked Spondyloepiphyseal Dysplasia Tarda
Gene(s) | Disorder | MOI | Clinical Features of Differential Diagnosis Disorder | Distinguishing Features/Comment |
|---|---|---|---|---|
CCN6(WISP3) | Progressive pseudorheumatoid dysplasia (PED) | AR | Predominant involvement of articular cartilage w/progressive joint stiffness enlargement w/o inflammation. | Unlike X-linked SEDT, joint swelling hand involvement are common features of PED. |
COL2A1 | SED congenita (SEDC) (See Type II Collagen Disorders Overview.) | AD1 |
Genetic testing for TRAPPC2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spondyloepiphyseal dysplasia tarda, X-linked has been reported in the published literature.
No approved treatments are currently available for spondyloepiphyseal dysplasia tarda, X-linked. The disease remains an area of unmet medical need.
To establish the extent of disease and needs in an individual diagnosed with X-linked spondyloepiphyseal dysplasia tarda (X-linked SEDT), the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended:
Table 3.
Recommended Evaluations Following Initial Diagnosis in Individuals with X-linked Spondyloepiphyseal Dysplasia Tarda
System/Concern | Evaluation | Comment
| Complete radiographic survey to incl scoliosis series if clinically indicated | To assess extent of skeletal manifestations
| • Flexion-extension radiographs of cervical spine
Flexion-extension MRI if instability compression seen on radiographs or interpretation on radiographs is limited (e.g., in young persons w/delayed ossification in upper cervical spine)
| To assess for clinically significant odontoid hypoplasia
Genetic
counseling | By genetics professionals1 | To inform affected persons their families re nature, MOI, implications of SEDT to facilitate medical personal decision making
MOI = mode of inheritance
1. Medical geneticist, certified genetic counselor, certified advanced genetic nurse
Treatment of Manifestations
Table 4.
Treatment of Manifestations in Individuals with X-linked Spondyloepiphyseal Dysplasia Tarda
Manifestation/Concern | Treatment | Considerations/Other
Odontoid
Source: GeneReviews — "X-Linked Spondyloepiphyseal Dysplasia Tarda"
The following should be avoided:
In individuals with odontoid hypoplasia, extreme neck flexion and extension
Activities and occupations that place undue stress on the spine and weight-bearing joints
Source: GeneReviews — "X-Linked Spondyloepiphyseal Dysplasia Tarda"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "X-Linked Spondyloepiphyseal Dysplasia Tarda"
View trials for spondyloepiphyseal dysplasia tarda, X-linked
Table 5. Recommended Surveillance for Individuals with X-linked Spondyloepiphyseal Dysplasia Tarda
System/Concern | Evaluation | Frequency |
|---|---|---|
Odontoid hypoplasia | Flexion-extension radiographs of cervical spine | Obtain prior to school age to assess for clinically significant odontoid hypoplasia. Scoliosis/ |
Kyphoscoliosis | Clinical eval w/spine radiographs if clinically indicated | Annually |
Osteoarthritis | Clinical eval for osteoarthritis | Annually |
Source: GeneReviews — "X-Linked Spondyloepiphyseal Dysplasia Tarda"
Phenotype severity distribution: 6 always present features.
No clinical trials have been registered for spondyloepiphyseal dysplasia tarda, X-linked.
111 publications have been identified in PubMed for spondyloepiphyseal dysplasia tarda, X-linked. Research spans Case Report / Case Series (45%), Basic Science / Preclinical (27%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 50 | 45% |
Laboratory research | 30 | 27% |
Research summaries | 19 | 17% |
Disease patterns and progression | 8 | 7% |
New treatment approaches | 2 | 2% |
Testing and diagnosis research | 1 | 1% |
Clinical study results | 1 | 1% |
Insalaco A (2026). [PMID: 41616907](https://pubmed.ncbi.nlm.nih.gov/41616907/). *Eur J Med Genet*. [Case Report / Case Series]
Zahfir I (2026). [PMID: 41320882](https://pubmed.ncbi.nlm.nih.gov/41320882/). *Mol Imaging Radionucl Ther*. [Case Report / Case Series]
Blaschitz A (2026). [PMID: 41985044](https://pubmed.ncbi.nlm.nih.gov/41985044/). *Eur J Endocrinol*. [Case Report / Case Series]
Portela Carvalho C (2026). [PMID: 41525162](https://pubmed.ncbi.nlm.nih.gov/41525162/). *Acta Med Port*. [Review / Meta-Analysis]
Au CW (2026). [PMID: 41174912](https://pubmed.ncbi.nlm.nih.gov/41174912/). *Am J Med Genet A*. [Case Report / Case Series]
Alqawlaq AK (2026). [PMID: 42231408](https://pubmed.ncbi.nlm.nih.gov/42231408/). *J Med Case Rep*. [Case Report / Case Series]
Halis M (2026). [PMID: 41549465](https://pubmed.ncbi.nlm.nih.gov/41549465/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Najdanović JG (2026). [PMID: 42131975](https://pubmed.ncbi.nlm.nih.gov/42131975/). *Hum Gene Ther*. [Review / Meta-Analysis]
Mu H (2026). [PMID: 41993173](https://pubmed.ncbi.nlm.nih.gov/41993173/). *Front Immunol*. [Clinical Trial Publication]
Merkuryeva ES (2026). [PMID: 42195013](https://pubmed.ncbi.nlm.nih.gov/42195013/). *Genes (Basel)*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 4:07 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Usually evident at birth w/disproportionate short stature, short extremities, broad chest, characteristic facies, myopia, incidence of cleft palate hearing loss. Delayed/poor ossification of vertebrae pubic bones; long bones are short w/hypoplastic epiphyses.
SED congenita is most common form of SED. |
Spondyloperipheral dysplasia (See Type II Collagen Disorders Overview.) | AD | Mild-to-moderate disproportionate short stature short extremities, brachydactyly type E, short ulnae, variable clubfeet, cleft palate, myopia, hearing loss; ovoid vertebra, delayed ossification of pubic bones, flattened irregular epiphyses in long bones. Premature hip arthrosis causes joint pain. | COL2A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 | — |
Stickler syndrome | ADAR2 | Connective tissue disorder; can incl high myopia, hearing loss (both conductive sensorineural); midfacial underdevelopment cleft palate (either alone or as part of Pierre Robin sequence); mild SED /or precocious arthritis. | COL9A1 COL9A2 COL9A3 COMP | — |
MATN3 | Multiple epiphyseal dysplasia, autosomal dominant (MED) | AD | Presents early in childhood, usually w/pain in hips /or knees after exercise; affected children complain of fatigue w/long-distance walking; waddling gait may be present. | — |
Source: GeneReviews — "X-Linked Spondyloepiphyseal Dysplasia Tarda"